Capsulitis News and Research

RSS
BioSpecifics reports net income of $2.7 million for fourth quarter 2015

BioSpecifics reports net income of $2.7 million for fourth quarter 2015

Auxilium seeks FDA approval for XIAFLEX sBLA to treat multiple Dupuytren's contracture cords concurrently

Auxilium seeks FDA approval for XIAFLEX sBLA to treat multiple Dupuytren's contracture cords concurrently

Auxilium doses first patient in CCH Phase 2b study for treatment frozen shoulder syndrome

Auxilium doses first patient in CCH Phase 2b study for treatment frozen shoulder syndrome

Auxilium Pharmaceuticals' XIAFLEX gets FDA approval for treatment of Peyronie's disease

Auxilium Pharmaceuticals' XIAFLEX gets FDA approval for treatment of Peyronie's disease

Auxilium Pharmaceuticals gets exclusive right to market VIVUS's STENDRA in the US and Canada

Auxilium Pharmaceuticals gets exclusive right to market VIVUS's STENDRA in the US and Canada

FDA extends PDUFA goal date for Auxilium Pharmaceuticals' sBLA for XIAFLEX

FDA extends PDUFA goal date for Auxilium Pharmaceuticals' sBLA for XIAFLEX

Auxilium Pharmaceuticals reports positive results from phase IIa Frozen Shoulder Syndrome clinical trial

Auxilium Pharmaceuticals reports positive results from phase IIa Frozen Shoulder Syndrome clinical trial

The Journal of Urology publishes results from BioSpecifics XIAFLEX trials on Peyronie's disease

The Journal of Urology publishes results from BioSpecifics XIAFLEX trials on Peyronie's disease

Shoulder complaint linked to diabetes diagnosis

Shoulder complaint linked to diabetes diagnosis

Musculoskeletal ultrasound being increasingly used for diagnosis and management of rheumatic diseases

Musculoskeletal ultrasound being increasingly used for diagnosis and management of rheumatic diseases

Cryotherapy effective for treating frozen shoulder

Cryotherapy effective for treating frozen shoulder

Robotic surgery shows promise for local control of OSCC

Robotic surgery shows promise for local control of OSCC

Auxilium initiates XIAFLEX phase IIa trial in Frozen Shoulder syndrome

Auxilium initiates XIAFLEX phase IIa trial in Frozen Shoulder syndrome

Emisphere's oral salmon calcitonin product addresses persistent musculoskeletal pain

Emisphere's oral salmon calcitonin product addresses persistent musculoskeletal pain

BioSpecifics Technologies' XIAFLEX receives marketing approval from FDA

BioSpecifics Technologies' XIAFLEX receives marketing approval from FDA